Time to Treatment Failure and Its Predictors Among Second-Line ART Clients in Amhara Region, Ethiopia: A Retrospective Follow-Up Study

References

• World Health Organization WHO. WHO fact sheet; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed April 29, 2024.
   Google Scholar
• World Health Organization Africa Health topics HIV/AIDS; 2018. Available from: https://www.afro.who.int/health-topics/hivaids#:~:text=In%20terms%20of%20people%20living,accounts%20for%205.4%20million%20PLHIV. Accessed April 29, 2024.
   Google Scholar
• Demsie DG, Bantie AT, Allene MD, Alema NM, Gebrie D. Antiretroviral treatment failure among HIV-positive adults taking first-line therapy and associated risk factors at Adigrat General hospital, Adigrat, Ethiopia 2019: a cross sectional study. Int J Surg Open. 2020;26:16–21. doi:10.1016/j.ijso.2020.08.001
   Web of Science ®Google Scholar
• Ethiopian factsheets UC. ETHIOPIA, FEDERAL MINSTRY OF HEALTH; 2021. Available from: https://www.unaids.org/en/regionscountries/countries/ethiopia. Accessed April 29, 2024.
   Google Scholar
• Ethiopia F. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. Addis Ababa: Fmoh; 2018:1–238.
   Google Scholar
• Laxmeshwar C, Acharya S, Das M, et al. Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India. PLoS One. 2020;15(5):e0232576. doi:10.1371/journal.pone.0232576
   PubMed Web of Science ®Google Scholar
• ETHIOPIA FMOH. National guidelines for comprehensive HIV prevention, care and treatment; 2014.
   Google Scholar
• Update UGA. Communities at the Centre—Defending Rights, Breaking Barriers, Reaching People with HIV Services. Geneva: Update UGA; 2019:316.
   Google Scholar
• Eholié SP, Aoussi FE, Ouattara IS, Bissagnéné E, Anglaret X. HIV treatment and care in resource‐constrained environments: challenges for the next decade. J Internat AIDS Soc. 2012;15(2):17334. doi:10.7448/IAS.15.2.17334
   PubMedGoogle Scholar
• Evans D, Hirasen K, Berhanu R, et al. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa. AIDS Res Ther. 2018;15(1):1–12. doi:10.1186/s12981-018-0196-9
   PubMedGoogle Scholar
• Alene M, Awoke T, Yenit MK, Tsegaye AT. Incidence and predictors of second-line antiretroviral treatment failure among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study. BMC Infect Dis. 2019;19(1):599. doi:10.1186/s12879-019-4243-5
   PubMed Web of Science ®Google Scholar
• Wong JK, Günthard HF, Havlir DV, et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proceed Nat Acad Sci 1997;94(23):12574–12579.
   PubMed Web of Science ®Google Scholar
• Collier D, Iwuji C, Derache A, et al. Virological outcomes of second-line protease inhibitor–based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a competing-risks prospective cohort analysis. Clinl Infect Dis. 2017;64(8):1006–1016. doi:10.1093/cid/cix015
   PubMed Web of Science ®Google Scholar
• Wandeler G, Keiser O, Mulenga L, et al. Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies. J Acqu Imm Defic Synd. 2012;61(1):41. doi:10.1097/QAI.0b013e3182632540
   PubMed Web of Science ®Google Scholar
• Ethiopian Public Helth Instituete (EPHIA). Final Report pdf; 2017.
   Google Scholar
• Endalamaw A, Mekonnen M, Geremew D, Yehualashet FA, Tesera H, Habtewold TD. HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020;20(1):1–12. doi:10.1186/s12889-020-8160-8
   PubMed Web of Science ®Google Scholar
• Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39:499–503. doi:10.2307/2531021
   PubMed Web of Science ®Google Scholar
• Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. JAMA. 2010;304(3):303–312. doi:10.1001/jama.2010.980
   PubMed Web of Science ®Google Scholar
• Tsegaye AT, Alemu W, Ayele TA. Incidence and determinants of mortality among adult HIV infected patients on second-line antiretroviral treatment in Amhara region, Ethiopia: a retrospective follow up study. Pan Afr Med J. 2019;2019:33.
   Google Scholar
• Edessa D, Sisay M, Asefa F. Second-line HIV treatment failure in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One. 2019;14(7):e0220159. doi:10.1371/journal.pone.0220159
   PubMed Web of Science ®Google Scholar
• Tsegaye AT, Wubshet M, Awoke T, Alene KA. Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study. BMJ open. 2016;6(12):e012537. doi:10.1136/bmjopen-2016-012537
   PubMed Web of Science ®Google Scholar
• Zenebe Haftu A, Desta AA, Bezabih NM, et al. Incidence and factors associated with treatment failure among HIV infected adolescent and adult patients on second-line antiretroviral therapy in public hospitals of Northern Ethiopia: multicenter retrospective study. PLoS One. 2020;15(9):e0239191. doi:10.1371/journal.pone.0239191
   PubMed Web of Science ®Google Scholar
• Haile D, Takele A, Gashaw K, Demelash H, Nigatu D. Predictors of treatment failure among Adult Antiretroviral Treatment (ART) clients in Bale zone hospitals, South Eastern Ethiopia. PLoS One. 2016;11(10):e0164299. doi:10.1371/journal.pone.0164299
   PubMed Web of Science ®Google Scholar
• Seid A, Cherie N, Ahmed K. Determinants of virologic failure among adults on second line antiretroviral therapy in Wollo, Amhara Regional State, Northeast Ethiopia. HIV/AIDS-Res Palliative Care. 2020;2020:697–706.
   Google Scholar
• Chimbetete C, Katzenstein D, Shamu T, et al. HIV-1 drug resistance and third-line therapy outcomes in patients failing second-line therapy in Zimbabwe. Paper presented at: Open forum infectious diseases; 2018.
   Google Scholar
• Cardoso SW, Luz PM, Velasque L, et al. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil. BMC Infect Dis. 2014;14(1):1–11. doi:10.1186/s12879-014-0699-5
   PubMedGoogle Scholar
• Underwood JM, Brener N, Ford CA. Amplifying improvements in the centers for disease control and prevention youth risk behavior surveillance system. J Adolesc Health. 2020;67(3):338–339. doi:10.1016/j.jadohealth.2020.06.023
   PubMed Web of Science ®Google Scholar
• Ding W-X, Yang L. Alcohol and drug-induced liver injury: metabolism, mechanisms, pathogenesis and potential therapies. Liver Res. 2019;3(3–4):129–131. doi:10.1016/j.livres.2019.11.006
   PubMedGoogle Scholar
• Babo YD, Alemie GA, Fentaye FW. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. PLoS One. 2017;12(11):e0187694. doi:10.1371/journal.pone.0187694
   PubMed Web of Science ®Google Scholar
• Thao VP, Quang VM, Wolbers M, et al. Second-line HIV therapy outcomes and determinants of mortality at the largest HIV referral center in Southern Vietnam. Medicine. 2015;94(43):e1715. doi:10.1097/MD.0000000000001715
   PubMed Web of Science ®Google Scholar
• Tegegne D, Mamo G, Negash B, Habte S, Gobena T, Letta S. Poor adherence to highly active antiretroviral therapy and associated factors among people living with HIV in Eastern Ethiopia. SAGE Open Medicine. 2022;10:20503121221104429. doi:10.1177/20503121221104429
   Web of Science ®Google Scholar